Laboratorios Farmaceuticos Rovi
ROVI.MC
#3618
Rank
S$4.63 B
Marketcap
S$90.69
Share price
0.33%
Change (1 day)
2.67%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2025 (TTM): S$0.36 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are S$1.05 Billion. In 2024 the company made an earning of S$0.37 Billion a decrease over its 2023 earnings that were of S$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.36 B-2.87%
2024 S$0.37 B-8.41%
2023 S$0.41 B15.62%
2022 S$0.35 B29.09%
2021 S$0.27 B149.21%
2020 S$0.11 B79.92%
2019 S$61.38 M128.6%
2018 S$26.85 M0.14%
2017 S$26.81 M-35.41%
2016 S$41.51 M28.52%
2015 S$32.3 M-32.56%
2014 S$47.89 M8.45%
2013 S$44.16 M-4.24%
2012 S$46.12 M2.62%
2011 S$44.94 M-3.29%
2010 S$46.46 M